Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics and Ozonated Olive Oil for Stage I/II Periodontitis
NCT06955546Completed
- Start
- Jan 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules, Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, triple-blind trial of Curasept Prevent and Curasept Prevent Probiotic in periodontitis (3 arms). Primary endpoints: Probing Pocket Depth at 30 days, Full Mouth Plaque Score at 30 days and 1 more. Started Jan 2023; status: completed.
02
Drugs
Curasept PreventCurasept Prevent Probiotic
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT06955546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06955546.